Up next

Autoplay

Sam Engel, MD: Sitagliptin versus Dapagliflozin for Older Diabetes Patients

1 Views • 08/26/25
Share
Side Effects
Side Effects
Subscribers
0

Vice President of Clinical Research at Merck talks about post-hoc analysis of a study that examined the efficacy of sitagliptin versus dapagiflozin.

Show more
0 Comments sort Sort By

Up next

Autoplay